Roche's Advancement Of Kidney Inflammation Drug Could Mark A Newly Available Treatment OptionSeeking Alpha • 09/25/19
5 High-Quality Dividend Contenders From Overseas To Diversify Your Dividend Growth PortfolioSeeking Alpha • 09/13/19
What Some Of The Largest Companies On OTC Markets Said In Their Most Recent Earnings ReportsBenzinga • 08/29/19
Seadrill Partners LLC (SDLP) CEO John Roche on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/20/19
Roche Sets An Immunotherapy First With Tecentriq Combination: Looks To Increase SalesSeeking Alpha • 08/13/19
The Hanover Insurance Group (THG) CEO Jack Roche on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/04/19